Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene

Pharmacogenetics

Volumn 11, Issue 8, 2001, Pages 727-733

  Mealey, K L ^a   Bentjen, S A ^a   Gay, J M ^a   Cantor, G H ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Canine; Collie; Dog; Ivermectin; mdr1 gene; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOG; DRUG SENSITIVITY; DRUG TRANSPORT; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GLYCOPROTEIN SYNTHESIS; HETEROZYGOSITY; HOMOZYGOSITY; MALE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STOP CODON;

ADMINISTRATION, ORAL; ANIMALS; ANTINEMATODAL AGENTS; BASE SEQUENCE; DOG DISEASES; DOGS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENES, MDR; IVERMECTIN; MALE; MOLECULAR SEQUENCE DATA; NEMATODE INFECTIONS; P-GLYCOPROTEIN;

CANIS FAMILIARIS;

EID: 0035164622     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200111000-00012     Document Type: Article

References (27)

1. Changes in the use profile of Mectizan: 1987-1997
2. Ivermectin: A review of efficacy and safety
3. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
4. Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive collies
5. The chemistry and pharmacology of avermectins
6. Immunohistochemical detection of P-gp in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues
7. Biochemistry of multidrug resistance mediated by the multidrug transporter
8. Ivermectin toxicosis in two Australian shepherds
9. Functional polymorphisms of the human multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
10. The safety of ivermectin
11. Loperamide poisoning in the dog
12. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein
13. Palindromic DNA and genome stability. Further studies
14. Molecular targets in oncology: Implications of the multidrug resistance gene
15. Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice
16. Clinical observations in collies given ivermectin orally
17. Safety of moxidectin in avermectin-sensitive collies
18. Investigating ivermectin toxicity in collies
19. Binding characteristics of ivermectin in plasma from collie dogs
20. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
21. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
22. Drugs used in the chemotherapy of helminthiasis
23. P-glycoprotein mediated efflux transport of anticancer drugs at the blood-brain barrier
24. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism
25. The functional role of P-glycoprotein in the blood-brain barrier
26. Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin
27. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies